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Anahtar sözcükler:
Langerhans hücreleri ve mast hücreleri kemik iliği kökenli hücreler olup dermis ve epidermisin immun
sisteminde kritik rol oynarlar. Biz bu çalışmada benign ve malign skuamoid tümörlerde mast hücre ve
Langerhans hücrelerinin rolünü değerlendirmeyi amaçladık.
Bu araştırmaya 12 seboreik keratoz, 9 aktinik keratoz, 15 keratoakantom ve 33 skuamöz
hücreli karsinom olgusu alındı. Dermal mast hücreleri ve epidermal peri ve intratümöral Langerhans hücreleri
sırasıyla mast hücre triptaz ve CD1a antikorlarıyla boyandı.
Mast hücre sayısı skuamöz hücreli karsinomda seboreik keratoza göre anlamlı olarak yüksekti
(p=0.001). Mast hücre sayısı diğer tümör grupları arasında farklılık göstermedi. İntratümöral Langerhans
hücreleri seboreik keratozda skuamöz hücreli karsinoma göre önemli oranda artmış saptandı (p=0.026).
Peritümöral Langerhans hücreleri ise skuamöz hücreli karsinom (p=0.007, p=0.001) ve keratoakantomda
(p=0.001, p=0.001), aktinik keratoz ve seboreik keratoza oranla artmışolarak saptandı.
Sonuç olarak biz çalışmamızda skuamöz hücreli karsinom ve keratoakantomda peritümöral
Langerhans hücreleri ve mast hücrelerini sayıca artmış bulduk. İmmün sistemde görevleri bulunan epidermal
Langerhans hücreleri ve dermal mast hücrelerinin benign ve malign deri tümörlerinde farklı rolleri olduğunu
düşündürmektedir.
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Langerhans cells and mast cells are bone marrow derived cells. They represent a critical role in the
immune system in the epidermis and dermis. In this present study, we aimed to evaluate the role of mast cells and
Langerhans cells in benign and malignant squamous tumors.
This study included 12 patients with seborrheic keratosis, 9 patients with
actinic keratosis, 15 patients with keratoacanthoma and 33 patients with squamous cell carcinoma. Dermal mast
cells and epidermal peri and intratumoral Langerhans cells were labeled with mast cell tryptase and CD1a
antibodies respectively.
The number of mast cells were significantly increased in the patients with squamous cell carcinoma
in comparison with seborrheic keratosis (p=0.001). However, this parameter did not show significant difference
between patients of other study groups. The number of intratumoral Langerhans cells in seborrheic keratosis were
significantly increased in comparison to squamous cell carcinoma (p=0.026). The peritumoral Langerhans cells
were increased in squamous cell carcinoma (p=0.007, p=0.001) and keratoacanthoma (p=0.001, p=0.001) in
comparison with actinic keratosis and seborrheic keratosis, respectively.
This immunohistochemical study demonstrates that peritumoral Langerhans cells and mast
cells are increased in number in keratoacanthoma and squamous cell carcinoma. Epidermal Langerhans cells and
dermal mast cells which have roles in the regulation of immune system might have different functions in benign
and malignant skin tumors.
Mast cells, Langerhans cells, skin tumors
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Immune cells of the epidermis and dermis
participate in the tumor progression and development.
Langerhans cells (LH cells) are bone marrow derived
dendritic cells that are typically localized in the basal
and suprabasal layers of the epidermis . They are
epidermal antigen presenting dendritic cells and they
protect skin against toxins, infections and
development of neoplasias . These cells represent a
critical role in the immune system at the interface to
the external environment. The LH cells are activated
by antigens, they invade and migrate through the
dermis and enter lymphatic capillaries. Than they
travel to the regional lymph nodes, where they present
antigenic peptides to T cells and trigger an antigen
specific immune response. For that reason LH cells are
referred to as “professional antigen-presenting cells”
.
Mast cells originate from the bone marrow and
represent a critical role in the immune system in the
dermis. They are often localized at highest density in
the perivascular area, and in close proximity to
peripheral nerves . They produce, store and release
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cytokines including keratinocyte growth and
differentiation factors, fibrogenic factors and
angiogenic factors . Studies have shown that mast
cells contribute to the tumorigenesis of cutaneous
malignancies through many mechanisms including
immunosupression, enhancement of angiogenesis,
degradation of the extracellular matrix and promotion
of tumor cell mitosis .
In the present study, we aimed to evaluate mast
cells and peri and intratumoral Langerhans cells in
some skin lesions including seborrheic keratosis (SK),
keratoacanthoma (KA), actinic keratosis (AK) and
squamous cell carcinoma (SCC).
This study included 12 patients with SK, 9
patients with AK, 15 patients with KA and 33 patients
with SCC. The distribution of histology, mean number
of mast cells and mean number of intratumoral and
peritumoral LH cells are demonstrated in Table I.
Dermal mast cells and epidermal LHs were labeled
with mast cell tryptase and CD1a antibodies.
The formalin fixed,
paraffin embedded sections were cut into 4µm
sections. The sections were deparaffinized with
xylene and hidrated through graded alcohols into
water. 3% hydrogen peroxide was applied for 30
minutes to inhibit endogenous peroxidase activity.
The primer antibody for Tryptase (Dako, Hamburg,
Germany) at a concentration of 1/50 was added and
slides were incubated for one hour. Then, they were
incubated in biotinylated goat anti-polyvalent
(Labvision, Fremont. CA, USA) for ten minutes and in
streptavidin peroxidase (Labvision, Fremont. CA,
USA) for twenty minutes. Finally the slides were
treated with AEC substrat system (Labvision,
Fremont. CA, USA) for tree minutes. The sections
were rinsed with water and was counterstained with
Mayer’s hematoxyline.
The entire tumor was scanned under low-power
magnification by light microscope. The number of
tryptase positive mast cells counted in three
representative, non overlapping, x200 microscopic
fields of the peripheral and central regions of each
tumor section. The means of mast cell numbers were
then calculated. Than the LH cells were counted in
three peritumoral and three intratumoral area and the
mean number were calculated.
Kolmogorov-Smirnov test was used to analyse
whether mast cells, intratumoral and peritumoral LH
cells had normal distribution. According to this test,
mast cells and LH cells had normal distribution.
Descriptive statistics were demonstrated as
mean–standard deviation (SD). One way analysis of
variance was used in the comparison of groups.
Tukey-HSD test was used for post hoc test. The
difference was considered as significant if p<0.05. The
correlation test was used to correlation between the
tumor subgroups.
The number of the mast cells was significantly
increased in the patients with SCC in comparison with
SK (p=0.001). However, this parameter did not show
significant difference between patients with SK and
AK and between patients with SK and KA (p=0.739,
p=0.427). The number of the mast cells obtained from
patients with SCC did not show significant difference
among patients with AK and KA (p=0.090, p=0.083).
Additionally the number of mast cells in AK and KA
did not show significant difference (p=0.987) (Fig 1,
2).
The number of the intratumoral LH cells
obtained from the patients with SK was significantly
increased in comparison with SCC (p=0.026). This
parameter did not show significant difference between
patients with SK and AK and between patients with
8
9
MATERIALS and METHODS
Immunohistochemistry:
Evaluation of immunostaining:
Statistical analysis
RESULTS
12
Table I. The distrubition of histology, mean number of mast cells and mean number of peri and intratumoral Langerhans cells.
Histology Number of
patients
Mean number of
mast cells
Mean number of
peritumoral LH cells
Mean number of
intratumoral LH cells
Seboreic keratosis 12 (17%) 24.4–9.3 26.5–12 48.5–22.5
Actinic keratosis 9 (13%) 29.6–14.2 27.1–13.5 29.3–7.9
Keratoacanthoma 15(22%) 31.3–11.2 50.9–20 34.1–19.7
Squamous cell carcinoma 33(48%) 40.1–11.8 45.5–12.5 29.8–19.4
Fig 1. Mast cells in KA (x400, tryptase).
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SK and KA (p=0.114, p=0.221). Any difference was
not observed between the patients with AK and KA
(p=0.933),AK and SCC (p=1.00) (Fig 3a, 3b, 3c).
Considering peritumoral LH cells, there was
significant difference between SK and KA (p=0.001),
SK and SCC (p=0.001), AK and KA (p=0.001), AK
and SCC (p=0.007). The number of peritumoral LH
cells were statistically insignificant between KA an
SCC (p=0.631). Peritumoral LH cells were highger in
KA and SCC compared with all other skin tumor
groups, and lowest in SK (Fig 3d).
When SK cases evaluated separately there was
not positive correlation between mast cells and peri-
intratumoral LH cells (p=0.868, p=0.469).
Additionally intra and peritumoral LH cells has no
correlation (p=0.856). In AK mast cells and peri-
intratumoral LH cells has no correlation (p=0.627,
p=0.842) but between peri and intratumoral LH cells
was positive correlation (p=0.006, r=0.830). In KA
mast cells and peri-intratumoral LH cells has no
correlation (p=0.580, p=0.694) but between peri and
intratumoral LH cells was positive correlation
Fig 2. Peritumoral mast cells in SCC (x400, tryptase).
Fig 3a. Numerous intratumoral LH cells in SK (x200, Cd1a).
Fig 3b. In this KA the intratumoral LH cells were increased
(x100, Cd1a).
Fig 3c. Increased intratumoral LH cells in AK (x200, Cd1a).
Fig 3d. Peritumoral LH cells are more in number than
intratumoral LH cells in SCC (x100, Cd1a).
(p<0.001, r=0.924). In SCC mast cells and peri-
intratumoral LH cells has no correlation (p=0.285,
p=0.062) but between peri and intratumoral LH cells
was positive correlation (p=0.002, r=0.525).
The stromal microenvironment, which in benign
and malign neoplasms is composed of vessels,
fibroblasts and several kinds of inflammatory cells,
influences tumor growth and progression. The skin
immune system play a central role of the cutaneous
tumor surveillance. The LH cells are an important
component of skin immune system . LH cells protect
skin against toxins, infections and development of
neoplasias . The most important biological role of LH
cells is to initiate an immune response. Following
uptake of antigen, LH cells mature and migrate into
draining lymph nodes.
vate T cells and trigger an antigen
specific immune response .
Recent studies have showed that LH cells are
reduced or increased in some cutaneous tumors .
Prior studies have shown a low density of LH cells in
SCC . Melo et al. suggested that LHs are more
numerous in normal skin and benign skin tumors in
comparison with malign skin tumors . Our
immunohistochemical study has demonstrated that
intratumoral LH cells are increased in number in SK.
The number of the intratumoral LH cells obtained
from the patients with SK was significantly increased
in comparison with SCC. In the other groups were not
difference. It remains unknown why LH cells are
increased in benign lesions and decreased in SCCs,
although it is suggested that it relates to immune
evasion by the tumor.
In the present series, peritumoral LH cells were
more numerous in KA. In SK and AK the number of
peritumoral LH cells were lower in number in
comparison with KA and SCC. The KA is a benign
epithelial tumor. It is sometimes difficult to
distinguish KA and SCC by histopathological
examination . Some believe that KA is a variant of
SCC . This is not generally accepted and many
authors believe that the two entities must be
distinguished, because KA have the potential to
involute without treatment. Regression is
immunologically mediated and activated by a variety
of molecular mechanisms . Are they a link between
peritumoral LH cells and regression in KAs? That is an
important point to understand of the tumor biology and
regression in some tumors including KAs.
Moreover there was strong positive correlation
between peri and intratumoral LH cells inAK, KAand
SCC. The intratumoral LH cells were more numerous
from peritumoral LH cells in SK. However the
peritumoral LH cells were more numerous than
intratumoral LH cells in SCC. Tumor infiltration by
LH cells has a positive prognostic implication because
of their increased ability to stimulate T cell responses
against the tumor .
Mast cells are multifunctional effector cells
rticipation in both adaptive and innate immune
system. The effects of the mast cell mediators alter the
dermal microenvironment .
It is suggested that ultraviolet-B activates mast
cells. Ultraviolet-B stimulates neuropeptide secretion
from dermal
. Hart et al. suggest that
mast cell histamine is an important mediator of
systemic suppression in mice . Mast cells have been
observed to accumulate around the margin of many
tumors and cutaneous malignancies . Recently
Grimbaldeston et. al suggested that mast cell products
may contribute to the initiation and development of
malignant melanoma . Additionally the number of
mast cells has been shown to be increased in the basal
cell carcinomas . It is suggested that a higher density
of dermal mast cell is a predisposing factor for the
development of basal cell carcinoma . However a
similar correlation has not been found for patients with
SCC . Our results show that mast cells were
significantly increased in the patients with SCC in
comparison with SK (p:0.001). The highest number of
mast cells were in SCC (Table 1). However there was
no significant difference between the other groups.
Aditionally there was no correlation between mast
cells and intra peritumoral LH cells.
These data suggest that mast cells can interact
with other immune cells and thereby contribute to the
development of cutaneous malignancies . In the
present study, the number of mast cells, peritumoral
and intratumoral LH cells indicated that there was
some variability in skin tumors. In addition, peri and
intratumoral LH cells have positive correlation in KA
and SCC.
In our opinion both epidermal Langerhans cells
and dermal mast cells which have some contributions
in the immune system, may have role in progression or
development of some skin tumors.
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Down regulation of E-cadherin
or IL-1β expression from keratinocytes is a key event
of LH cells migration. In the lymph nodes they enter
the afferent lymphatic vessels to initiate systemic
immune responses. In T cell compartments of lymph
nodes, they acti
of
immune system. Mature mast cells produce and
release a wide variety of soluble mediators, such as
tryptase and chymase, histamine, heparin, leukotriene
C4, prostaglandin D2 and multifunctional cytokines
including TNF-α, IL-4, IL-10 that enable their
pa
sensory nerves. These neuropeptides
release mediators from mast cells such as Histamine
and TNF-α . Mast cells are the major source of
TNF-α in human skin. It is suggested that TNF-α is a
key mediator in ultraviolet-induced local
immunosupression. TNF-α is increased in sun
exposed skin and it may act by altering LH cell
morphology and function
14
Benign ve Malign Neoplastik Deri Lezyonlarında Epidermal
REFERENCES
1. Koch S, Kohl K, Klein E, Bubnoff D, Bieber T. Skin
homing of langerhans cell precursors: adhesion,
chemotaxis, and migration. J Allergy Clin Immunol
2006;17:163-8.
2. Melo MR, Filho JLA, Patu VJR, Machado MCF, Mello
LA, Carvalho LB. Langerhans cells in cutaneous
tumors: immunohistochemistry study using a computer
image analysis system. J Mol Histol 2006;37:321-5.
3. Rotsztejn H, Budzko ET, Kupnicka DJ. Langerhans cell
in vulvar lichen sclerosus and vulvar squamous cell
carcinoma.Arch Immunol Ther Exp 2006;54:363-6.
4. Holikova Z, Hercokova J, Plzak J, Smetana K.
Dendritic cells and their role in skin induced immune
responses. JEADV 2001;15:116-20.
5. Fieber C, Baumann P, Vallon R, Termeer C, Simon JC,
Hofmann M, Angel P, Herrlich P, Sleeman JP.
Hyaluronan oligosaccharide induced transcription of
metalloproteases. J Cell Science 2003;117:359-67.
6. Valladeau J, Saeland S. Cutaneous dendritic cells. Sem
Immunol 2005;17:273-83.
7. Grimbaldeston MA, Finlay-Jones JJ, Hart PH. Mast
cells in photodamaged skin: what is their role in skin
cancer? Photochem Photobiol Sci 2006;5:177-83.
8. Grimbaldeston MA, Skov L, Finlay-Jones JJ, Hart PH.
Squamous cell carcinoma is not associated with high
dermal mast cell prevalence in humans. J Invest
Dermatol 2002;119:1204-6.
9. Ching S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast
cells and cutaneous malignanacies. Mod Pathol
2006;19:149-59.
10. Woods GM, Malley RC, Muller HK. The skin immune
s y s t e m a n d t h e c h a l l e n g e o f t u m o u r
immunosurveillance. Eur J Dermatol 2005;15:63-9.
11. McArdle JP, Knight BA, Halliday GM, Muller HK,
Rowden G. Quantitative assesment of langerhans cells
in actinic keratosis, bowens disease, keratoacanthoma,
squamous cell carcinoma and basal cell carcinoma.
Pathology 1986;18:212-6.
12. Berhane T, Halliday GM, Cooke B, Barnetson RSC.
Inflammation is associated with progression of actinic
keratosis to squmous cell carcinoma. Br J Dermatol
2002;146:810-5.
13. Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, TuY,
MoroiY, Furue M. Stromal CD10 expression, as well as
increased dermal macrophages and decreased
Langerhans cells, are associated with malignant
transformation of keratinocytes. J Cutan Pathol
2009;36:668-74.
14. Rotsztejn H, Budzko ET, Kupnicka DJ. Do Langerhans
cells play a role in vulvar epithelium resistance to
squamous cell carcinoma? Arch Immunol Ther Exp
2007;55:127-30.
15. Cribier B, Asch PH, Grosshans E. Differentiating
squamous cell carcinoma from keratoacanthoma using
histopathological criteria. Dermatol 1999;199:208-12.
16. Hodak E, Jones RE, Ackerman AB. Solitary
keratoacanthoma is a squamous cell carcinoma. Am J
Dermatopathol 1993;15: 332-42.
17. Patel A, Halliday GM, Cooke BE, Barnetson RStcC.
Evidence that regression in keratoacanthoma is
immunologically mediated: a comparison with
squamous cell carcinoma. Br J Dermatol 1994;131:
789-98.
18. Beham A, Reqauer S, Soyer HP, Beham-Schmid C.
Keratoacanthoma: a clinically distinct variant of well
differentiated squamous cell carcinoma. Adv Anat
Pathol 1998;5: 269-80.
19. Tataroğlu C, Karabacak T, Apa DD.
20. Gomes APN, Johann JE, Lovato GG, Ferreira AM.
Comparative analysis of the mast cell density in normal
oral mucosa, actinic cheilitis and lip squamous cell
carcinoma. Braz Dent J 2008;19:186-9.
21. Diaconu NC, Kaminska R, Naukkarinen A, Harvima
RJ, Nilsson G, Harvima IT. Increase in CD30
ligand/CD153 a
22. Hart PH, Grimbaldeston MA, Finlay-Jones JJ.
Sunlight, immunosuppression and skin cancer: role of
histamine and mast cells. Clin Exp Pharmacol Phisiol
2001;28:1-8.
24. Hart PH, Townley SL, Grimbaldeston MA, Khalil Z,
Finlay-Jones JJ. Mast cells, neuropeptides, histamine,
and prostaglandins in uv-induced systemic
immunosuppression. Methods 2002;28:79-89.
25. Tataroğlu C, KargıA, Özkal S, Eşrefoğlu N,AkkoçluA.
Association of macrophages, mast cells and eosinophil
leukocytes with angiogenesis and tumor stage in non-
small lung carcinomas (NSCLC). Lung Cancer
2004;43:47-54.
26. Aoki M, Pawankar R, Nimi Y. Mast cells in bsal cell
carcinoma express VEGF, IL-8 and RANTES. Int Arch
Allergy Immunol 2003;130:216-23.
27. Reed JA, McNutt NS, Bogdany JK, Albino AP.
Expression of the mast cell growth factor interleukin-3
in melanocytic lesions correlates with an increased
number of mast cells in the perilesional stroma:
implications for melanoma progression. J Cutan Pathol
1996;23:495-505.
28. Grimbaldeston MA, Pearce AL, Robertson BO,
Coventry BJ, Marshman G. Association between
melanoma and dermal mast cell prevalance in
sunexposed skin. Br J Dermatol 2004;150:895-903.
29. Grimbaldeston MA, Skov L, Finlay-Jones JJ, Hart PH.
Increased dermal mast cell prevalance and
susceptibility to development of basal cell carcinoma in
humans. Methods 2002;28:90-6.
30. Grimbaldeston MA, Skov L, Ole Baadsgaard, Skov
BG, Marhman G, Finlay-Jones JJ, Hart PH. High
dermal mast cell prevalence is a predisposing factor for
basal cell carcinoma in humans. J Invest Dermatol
2000;115:317-20.
β
nd -α
23.
-catenin and
CD44 expression in keratoacanthoma and squamous
cell carcinoma of the skin. Tumori 2007;93:284-9.
TNF expressing mast cells in
basal cell carcinoma. Cancer Immunol Immunother
2007;56:1407-15.
Walsh LJ. Ultraviolet B irradiation of skin induces mast
cell degranulation and release of tumor necrosis factor-
α. Immunol Cell Biol 1995;73:226-33.
15
Tataroğlu ve Ark.
YAZIŞMA ADRESİ
Telefon :
E-Posta :
Geliş Tarihi :
Kabul Tarihi :
Doç. Dr. Canten TATAROĞLU
Adnan Menderes Üniversitesi Tıp Fakültesi, Patoloji
Anabilim Dalı, AYDIN, TÜRKİYE
256 4441256
cantent@yahoo.com
14.12.2010
01.04.2011
16
Benign ve Malign Neoplastik Deri Lezyonlarında Epidermal
